Foamix Pharmaceuticals Ltd. Comprehensive Income
Foamix Pharmaceuticals Ltd. reported Comprehensive Income of -$95.13 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2020-03-12
- Foamix Pharmaceuticals Ltd. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-12-31 was -$37.82M.
- Foamix Pharmaceuticals Ltd. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-09-30 was -$23.16M.
- Foamix Pharmaceuticals Ltd. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-06-30 was -$19.00M.
- Foamix Pharmaceuticals Ltd. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-03-31 was -$15.15M.
- Foamix Pharmaceuticals Ltd. comprehensive income (loss), net of tax, attributable to parent for fiscal 2019 was -$95.13M.
- Foamix Pharmaceuticals Ltd. comprehensive income (loss), net of tax, attributable to parent for fiscal 2018 was -$74.11M.
- Foamix Pharmaceuticals Ltd. comprehensive income (loss), net of tax, attributable to parent for fiscal 2017 was -$65.71M.
- Foamix Pharmaceuticals Ltd. comprehensive income (loss), net of tax, attributable to parent for fiscal 2016 was -$29.27M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$37.82M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$60.98M derived: sum of 2 quarters · filed 2020-03-12 | -$79.98M derived: sum of 3 quarters · filed 2020-03-12 | -$95.13M 10-K · filed 2020-03-12 |
| 2019-09-30 | -$23.16M 10-Q · filed 2019-11-12 | -$42.16M derived: sum of 2 quarters · filed 2019-11-12 | -$57.31M 10-Q · filed 2019-11-12 | -$71.38M derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-06-30 | -$19.00M 10-Q · filed 2019-08-07 | -$34.16M 10-Q · filed 2019-08-07 | -$48.22M derived: sum of 3 quarters · filed 2020-03-12 | -$63.63M derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-03-31 | -$15.15M 10-Q · filed 2019-05-07 | -$29.22M derived: sum of 2 quarters · filed 2020-03-12 | -$44.63M derived: sum of 3 quarters · filed 2020-03-12 | -$63.26M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-12-31 | -$14.06M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$29.47M derived: sum of 2 quarters · filed 2020-03-12 | -$48.10M derived: sum of 3 quarters · filed 2020-03-12 | -$74.11M 10-K · filed 2020-03-12 |
| 2018-09-30 | -$15.41M 10-Q · filed 2019-11-12 | -$34.04M derived: sum of 2 quarters · filed 2019-11-12 | -$60.05M 10-Q · filed 2019-11-12 | -$77.48M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | -$18.63M 10-Q · filed 2019-08-07 | -$44.64M 10-Q · filed 2019-08-07 | -$62.07M derived: sum of 3 quarters · filed 2020-03-12 | -$79.64M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | -$26.01M 10-Q · filed 2019-05-07 | -$43.44M derived: sum of 2 quarters · filed 2020-03-12 | -$61.01M derived: sum of 3 quarters · filed 2020-03-12 | -$77.38M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | -$17.43M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$35.00M derived: sum of 2 quarters · filed 2020-03-12 | -$51.37M derived: sum of 3 quarters · filed 2020-03-12 | -$65.71M 10-K · filed 2020-03-12 |
| 2017-09-30 | -$17.57M 10-Q · filed 2018-11-07 | -$33.94M derived: sum of 2 quarters · filed 2018-11-07 | -$48.28M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | -$16.37M 10-Q · filed 2018-08-08 | -$30.71M 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | -$14.34M 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | -$29.27M 10-K · filed 2019-02-28 | |||
| 2016-06-30 | -$8.24M 6-K · filed 2017-08-08 | -$12.52M 6-K · filed 2017-08-08 | ||
| 2015-12-31 | -$16.57M 10-K · filed 2018-03-01 | |||
| 2015-06-30 | -$4.57M 6-K · filed 2016-08-10 | -$7.59M 6-K · filed 2016-08-10 | ||
| 2014-12-31 | -$11.56M 20-F · filed 2017-02-21 | |||
| 2014-06-30 | -$3.40M 6-K · filed 2015-10-19 | -$3.44M 6-K · filed 2015-10-19 | ||
| 2013-12-31 | -$2.43M 20-F · filed 2016-03-02 | |||
| 2012-12-31 | -$2.17M 20-F · filed 2015-03-17 |